October 2025
1. TISDALE JE, Jaynes HA, Overholser BR, Sowinski KM, et al
   Dihydrotestosterone Pretreatment Diminishes the Severity of Drug-Induced Torsades de Pointes.
   J Cardiovasc Pharmacol. 2025;86:343-349.
   

   >> Share

   
   July 2025
2. AVE MT, Brion M, Blanco-Verea A, Gil A, et al
   Relevance of CYP2D6 in the Efficacy and Toxicity of Flecainide in Patients with Atrial Fibrillation: A Cohort Study.
   J Cardiovasc Pharmacol. 2025 Jul 24. doi: 10.1097/FJC.0000000000001739.
   

   >> Share

   
   
3. FAGHIHI M, Ahmadi-Beni M, Houshmand F
   Role of Muscarinic Acetylcholine Receptors in Oxytocin-Induced Cardioprotection Against Ischemia-Reperfusion Injury in Rats.
   J Cardiovasc Pharmacol. 2025;86:109-117.
   

   >> Share

   
   May 2025
4. ATMACA H, Yetkin E
   Coupling Interval Ratio to Predict the Beta-Blocker Response Against Premature Ventricular Complexes.
   J Cardiovasc Pharmacol. 2025;85:364-368.
   

   >> Share

   
   March 2025
5. SAMOS M, Skerenova M, Nosal V, Skornova I, et al
   ABCB1 gene single nucleotide variants and haplotypes in atrial fibrillation patients experiencing adverse events on direct oral anticoagulation: a whole gene exome sequencing study.
   J Cardiovasc Pharmacol. 2025 Mar 28. doi: 10.1097/FJC.0000000000001695.
   

   >> Share

   
   
6. AHUJA T, Saadi R, Papadopoulos J, Bernard S, et al
   Digoxin Loading Doses and Serum Digoxin Concentrations for Rate Control of Atrial Arrhythmias in Critically Ill Patients.
   J Cardiovasc Pharmacol. 2025;85:211-216.
   

   >> Share

   
   January 2025
7. ZHANG X, Liu J, Shi Y, Wang H, et al
   Effect of different doses of dexmedetomidine on atrial fibrillation in adults after cardiac surgery.
   J Cardiovasc Pharmacol. 2025 Jan 23. doi: 10.1097/FJC.0000000000001674.
   

   >> Share

   
   December 2024
8. HAKGOR A, Olgun FE, Dursun A, Kahraman BC, et al
   Sodium glucose cotransporter 2 inhibitors improve long-term atrial fibrillation-free survival after catheter ablation.
   J Cardiovasc Pharmacol. 2024 Dec 31. doi: 10.1097/FJC.0000000000001656.
   

   >> Share

   
   November 2024
9. SCHULZ C, Eschenhagen T, Christ T
   Atrial hiPSC-CM as a Pharmacologic Model to Evaluate Anti-AF Drugs: Some Lessons From I Kur.
   J Cardiovasc Pharmacol. 2024;84:479-485.
   

   >> Share

   
   October 2024
10. DAKROUB A, Beaini H, Kibbi R, Moumneh MB, et al
    Comparative Analysis of Anticoagulation Versus Combination Anticoagulation and Antiplatelet Therapy in Atrial Fibrillation Patients Presenting With Gastrointestinal Bleeding.
    J Cardiovasc Pharmacol. 2024 Oct 10. doi: 10.1097/FJC.0000000000001641.
    

    >> Share

    
    September 2024
11. ISMAILI D, Petersen J, Schulz C, Eschenhagen T, et al
    PDE8 Inhibition and Its Impact on ICa,L in Persistent Atrial Fibrillation: Evaluation of PDE8 as a Potential Drug Target.
    J Cardiovasc Pharmacol. 2024 Sep 13. doi: 10.1097/FJC.0000000000001630.
    

    >> Share

    
    August 2024
12. WU L, Li Z, Xu L, Fan Y, et al
    Nrf2 ameliorates atrial fibrosis during antithrombotic therapy for atrial fibrillation by modulating CYP2C9 activity.
    J Cardiovasc Pharmacol. 2024 Aug 12. doi: 10.1097/FJC.0000000000001618.
    

    >> Share

    
    
13. ZOU Y, Liu X, Hu Y, Zhang C, et al
    Inhibition of alpha-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic Acid Receptors Ameliorates Atrial Inflammation and Vulnerability to Atrial Fibrillation in Rats with Anxiety Disorders.
    J Cardiovasc Pharmacol. 2024;84:227-238.
    

    >> Share

    
    
14. GOLINO M, Lazzerini PE
    Hydroxychloroquine, Chloroquine, and Arrhythmic Risk in Systemic Autoimmune Diseases: Focus More on the Patient and You Will Keep the Rhythm!
    J Cardiovasc Pharmacol. 2024;84:149-151.
    

    >> Share

    
    
15. NIKOLIC RPA, Virk MK, Buhler KA, Costenbader KH, et al
    Hydroxychloroquine and Chloroquine-Induced Cardiac Arrhythmias and Sudden Cardiac Death in Patients With Systemic Autoimmune Rheumatic Diseases: A Systematic Review and Meta-Analysis.
    J Cardiovasc Pharmacol. 2024;84:158-169.
    

    >> Share

    
    July 2024
16. BURASHNIKOV A, Antzelevitch C
    The efficacy of INa block to cardiovert atrial fibrillation is enhanced by inhibition of IK1.
    J Cardiovasc Pharmacol. 2024 Jul 29. doi: 10.1097/FJC.0000000000001617.
    

    >> Share

    
    
17. ZHANG J, Xiong X, Li J, Luo C, et al
    Valtrate suppresses TNFSF14-mediated arrhythmia after myocardial ischemia-reperfusion via inducing N-linked glycosylation of LTbetaR to regulate MGA/MAX/c-Myc/Cx43.
    J Cardiovasc Pharmacol. 2024 Jul 19. doi: 10.1097/FJC.0000000000001613.
    

    >> Share

    
    March 2024
18. CHEN YF, Liu NN, Wang JY, Sun JS, et al
    Use of 3D echocardiography facilitates analysis of thrombolytic efficacy in patients with persistent atrial fibrillation.
    J Cardiovasc Pharmacol. 2024 Mar 25. doi: 10.1097/FJC.0000000000001567.
    

    >> Share

    
    December 2023
19. RIVERA FB, Cha SW, Aparece JP, Jariyatamkitti S, et al
    Efficacy and safety of colchicine for the prevention of postoperative atrial fibrillation among patients undergoing major cardiothoracic surgery: a meta-analysis and meta-regression of randomized controlled trials.
    J Cardiovasc Pharmacol. 2023 Dec 28. doi: 10.1097/FJC.0000000000001533.
    

    >> Share

    
    
20. SPADAFORA L, Gaudio C, Biondi-Zoccai G, Frati G, et al
    Catalysts of cardiovascular electromechanical harmony? Unveiling the impact of RAS Inhibitors and ARNI on atrial fibrillation recurrence after ablation.
    J Cardiovasc Pharmacol. 2023 Dec 27. doi: 10.1097/FJC.0000000000001537.
    

    >> Share

    
    November 2023
21. SUN Q, Cui W, Zhang X, Tian Y, et al
    A Systematic Review and Meta-analysis of Renin-angiotensin Inhibitors and Angiotensin Receptor Neprilysin Inhibitors in Preventing Recurrence after Atrial Fibrillation Ablation.
    J Cardiovasc Pharmacol. 2023 Nov 22. doi: 10.1097/FJC.0000000000001517.
    

    >> Share

    
    September 2023
22. AMARH E, Tisdale JE, Overholser BR
    Prolonged Exposure to Remdesivir Inhibits the Human Ether-A-Go-Go-Related Gene Potassium Current.
    J Cardiovasc Pharmacol. 2023;82:212-220.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share